Disclosed is a process for the conversion of acyclic C.sub.5 feedstock to a product comprising cyclic C.sub.5 compounds, including cyclopentadiene, and catalyst compositions for use in such process. The process comprises contacting the feedstock and, optionally, hydrogen under acyclic C.sub.5 conversion conditions in the presence of a catalyst composition to form said product. The catalyst composition comprises a microporous crystalline metallosilicate, a Group 10 metal or compound thereof, and a Group 11 metal or compound thereof.

One-step cyanide-catalyzed benzoin condensations for synthesizing shape persistent cyclobenzoin macrocycles. Selected dialdehydes, and cyanide salts are reacted in aqueous solvents to form such cyclobenzoin macrocycles.

The present invention describes an oligomer for use as a UV stabiliser. In particular, the oligomer is suitable for use as a UV stabiliser in a polymer matrix. The present invention also describes a method of forming said oligomer. The method of forming said oligomer comprises a polymerising step, wherein the polymerising step comprises forming a CC bond on the hydroxyphenyl ring of a monomer. In preferred embodiments, the oligomer is formed from polymerizing bio-derived monomer such as curcumin, its hydrogenated analogue, and an aldol condensation product of cyclic ketone and vanillin.

Disclosed is a process for the conversion of acyclic C.sub.5 feedstock to a product comprising cyclic C.sub.5 compounds, such as for example, cyclopentadiene, and catalyst compositions for use in such process. The process comprising the steps of contacting said feedstock and, optionally, hydrogen under acyclic C.sub.5 conversion conditions in the presence of a catalyst composition to form said product. The catalyst composition comprising a microporous crystalline ferrosilicate, a Group 10 metal, and, optionally, a Group 11 metal, in combination with an optional Group 1 alkali metal and/or an optional Group 2 alkaline earth metal.

Disclosed is a process for the conversion of acyclic C.sub.5 feedstock to a product comprising cyclic C.sub.5 compounds, such as for example, cyclopentadiene, and catalyst compositions for use in such process. The process comprising the steps of contacting said feedstock and, optionally, hydrogen under acyclic C.sub.5 conversion conditions in the presence of a catalyst composition to form said product. The catalyst composition comprising a crystalline aluminosilicate having a constraint index of less than or equal to 5, and a Group 10 metal, and, optionally, a Group 11 metal, in combination with a Group 1 alkali metal and/or a Group 2 alkaline earth metal.

Disclosed is a process for the conversion of acyclic C.sub.5 feedstock to a product comprising cyclic C.sub.5 compounds, including cyclopentadiene, and catalyst compositions for use in such process. The process comprises contacting the feedstock and, optionally, hydrogen under acyclic C.sub.5 conversion conditions in the presence of a catalyst composition to form said product. The catalyst composition comprises a microporous crystalline metallosilicate, a Group 10 metal or compound thereof, and a Group 11 metal or compound thereof.

Disclosed is a process for the conversion of acyclic C.sub.5 feedstock to a product comprising cyclic C.sub.5 compounds, such as, for example, cyclopentadiene, and catalyst compositions for use in such process. The process comprises the steps of contacting said feedstock and, optionally, hydrogen under acyclic C.sub.5 conversion conditions in the presence of a catalyst composition to form said product. The catalyst composition comprising a microporous crystalline aluminosilicate having a constraint index in the range of 3 to 12, a Group 10 metal, and, optionally, a Group 11 metal, in combination with a Group 1 alkali metal and/or a Group 2 alkaline earth metal.

Disclosed is a process for the conversion of acyclic C.sub.5 feedstock to a product comprising cyclic C.sub.5 compounds, such as for example, cyclopentadiene, and catalyst compositions for use in such process. The process comprising the steps of contacting said feedstock and, optionally, hydrogen under acyclic C.sub.5 conversion conditions in the presence of a catalyst composition to form said product. The catalyst composition comprising a microporous crystalline ferrosilicate, a Group 10 metal, and, optionally, a Group 11 metal, in combination with an optional Group 1 alkali metal and/or an optional Group 2 alkaline earth metal.

A compound represented by formula I, and a racemate, stereoisomer, tautomer, solvate, polymorph, or pharmaceutically acceptable salts thereof are provided. The compound has good prostate tumor cell proliferation inhibitory activity and anti-AR activity. The compound has good in-vivo metabolic properties, has high AUC and C.sub.max, is good in druggability, and can be used for preventing and/or treating androgen-related disorders. The compound also has a good hair growth promoting effect, and can effectively increase the number of hair follicles and the growth length of hair.

##STR00001##